Timing of revascularization after acute myocardial infarction

Mohammed M Abd-Alaal1, Mostafa A Alsabban, Osama A Abbas

  • 1Heart Sciences Department, King Fahad Cardiac Center, King Saud University, Riyadh, Saudi Arabia. malaal2@hotmail.com

Insights

Timing of coronary artery bypass surgery after acute myocardial infarction impacts outcomes. Emergency surgery within 24 hours showed higher mortality and complications compared to delayed procedures.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Outcomes Research

Background:

  • Optimal timing for surgical revascularization post-acute myocardial infarction (AMI) is debated.
  • Emergency coronary artery bypass grafting (CABG) is associated with increased mortality.
  • Evidence regarding the impact of revascularization timing on patient outcomes is limited.

Purpose of the Study:

  • To investigate the relationship between the timing of surgical revascularization and patient outcomes following acute myocardial infarction.
  • To compare mortality and morbidity rates across different time intervals from AMI onset to CABG.

Main Methods:

  • Retrospective review of 278 patients undergoing CABG between 2005 and 2007.
  • Patients were stratified into three groups based on time from AMI onset to surgery: within 24 hours, 24-72 hours, and after 14 days.
  • Outcomes analyzed included mortality and postoperative complications.

Main Results:

  • Mortality rates were 11.7% for surgery within 24 hours, 7% for surgery at 24-72 hours, and 2.5% for surgery after 14 days.
  • The group undergoing surgery within 24 hours had the highest incidence of postoperative complications.
  • Early revascularization (within 24 hours) was linked to significantly higher risks of mortality and morbidity.

Conclusions:

  • Surgical revascularization within 24 hours of acute myocardial infarction is associated with increased mortality and morbidity.
  • Delaying surgical revascularization beyond 72 hours appears to improve patient outcomes.
  • These findings suggest that a non-emergency approach to CABG after AMI may be beneficial.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...